About Nanjing Highrui Technology

Nanjing Highrui Technology Co., Ltd. is a high-tech enterprise established in June 2024, located in Nanjing, Jiangsu Province, China. The company focuses on the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), committed to providing global customers with high-quality pharmaceutical product solutions.

Corporate Vision and Mission:

Nanjing Highrui Technology Co., Ltd. adheres to the corporate spirit of "professionalism, quality, and service," and is committed to becoming a leader in the pharmaceutical industry. We continuously innovate in technology and upgrade products to provide customers with efficient, safe, and reliable pharmaceutical intermediates and active pharmaceutical ingredients (APIs), in order to meet the growing market demand.

 

Main Business:

The core business of the company covers the research and development and production of pharmaceutical intermediates and APIs. Our products are widely used in various therapeutic areas, including but not limited to diabetes, cardiovascular and cerebrovascular diseases, digestive system medicines, and cosmetics. The company ensures high standards and high purity of its products through a strict quality control system and advanced production technology.

 

Market and Cooperation:

The company's products are not only highly regarded in the domestic market but also sold to various countries and regions. Nanjing Highrui Technology Co., Ltd. has established solid cooperative relationships with many well-known domestic and international pharmaceutical companies, jointly promoting the development of the pharmaceutical industry.

 

Quality Control:

The company follows international quality standards and has established a comprehensive quality management system. From raw material procurement to product shipment, every link is strictly tested and controlled to ensure the stability and reliability of product quality.

 

Nanjing Highrui Technology Co., Ltd. will continue to be committed to deep cultivation in the field of pharmaceuticals, providing customers with higher quality products and services through continuous technological innovation and market expansion, and contributing to the cause of human health.